Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antitrust
Pharma
Appeals court backs Regeneron's antitrust suit against Novartis
Novartis and Vetter must now defend against Regeneron's allegation that the companies conspired to delay a prefilled syringe version of Eylea.
Angus Liu
Mar 19, 2024 10:40am
Sandoz ponies up $265M to settle lingering price-fixing case
Feb 29, 2024 10:49am
Pfizer quells 12 years of Lipitor antitrust litigation with $93M
Feb 15, 2024 11:11am
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
Nov 21, 2023 11:34am
Indivior to fork over $385M in Suboxone antitrust settlement
Oct 23, 2023 1:37pm
EU authorities fine Boehringer, others for operating 'cartel'
Oct 23, 2023 10:13am